You are here

Article Text

Article menu

Download PDFPDF

Miscellanea
New combination therapy improves survival in non-small cell lung cancer
Free
  1. Vinod Aiyappan
  1. Specialist Registrar (LAT) in Respiratory Medicine, Queen Elizabeth Hospital, Kings Lynn, Norfolk, UK; drvinodaiyappan@doctors.org.uk

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    ▴ Sandler A, Gray R, Perry MC, et al. Paclitaxel–carboplatin alone or with bevacizumab for non–small-cell lung cancer. N Engl J Med2006;355:2542–50.OpenUrlCrossRefPubMedWeb of Science

    The survival rate of patients with metastatic non-small-cell lung cancer remains poor even with chemotherapy. This randomised-controlled trial looks at the effect of monoclonal antibody against vascular endothelial …

    View Full Text